The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
about
Update in juvenile myositisMuscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).Developing a provisional, international minimal dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research.Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damageAnalysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is UnderestimatedMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study.Consensus-based recommendations for the management of juvenile dermatomyositis.In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity.Disease activity measures in paediatric rheumatic diseasesIn juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset.Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.Modelling disease activity in juvenile dermatomyositis: A Bayesian approach.Juvenile dermatomyositis: a tertiary center experience.Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus.Efficacy of ultrasound elastography in detecting active myositis in children: can it replace MRI?Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis.Efficacy and safety of creatine supplementation in juvenile dermatomyositis: A randomized, double-blind, placebo-controlled crossover trial.Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspectsClinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study
P2860
Q26822598-7CA63281-C893-4429-9262-77C76B69879CQ33556620-C428895C-AD6E-4E88-A66D-A5A200A89DB3Q33962448-8B10DF18-FCF1-4FC7-B90C-C56D85BC3E7AQ34486301-D6EB0A3D-79FC-4AED-9174-FF204B7C135BQ34563223-A01AA105-AA5C-454F-8880-7B6909172539Q35125063-01ADC256-C147-4745-8CA7-488E9A1C1E95Q36532789-33DCE1E3-6D1E-46BD-AB73-6D5FAF87736EQ37368405-05080959-7A5C-4BDC-908B-CA4DCECBD98AQ37410392-BD819E03-DD7E-40F1-8FCD-E96340E2D78CQ37617000-B7F6D5F3-ABBF-4C2A-A8A9-D066EA80FB1AQ38123764-CF8CDB83-8499-45CB-ADD3-5797122CD71CQ38148751-C9F29566-3B5D-495E-979E-270DADFF4222Q38616245-05AD73DB-6A2E-479D-8597-832165F25A76Q38690044-2EAFD11B-497C-4B4D-B859-A426FC71BFE5Q38738961-E8DDF46B-776C-411C-96CB-AD48AA9B9086Q39036962-7D420EDE-5987-4AFA-8B00-57B71D0FFADFQ40829949-6F437924-4E85-4D68-9E1F-3068D55CDE66Q41026824-457D393C-F414-4937-9F5C-79CD60D6D9A1Q47800428-B27001CA-BDC8-4040-9A18-E529963DDEC3Q48040258-A2AD8864-1ABA-4A5F-84C5-59C246CCCC81Q53092243-1A27DDD7-6F68-49A8-992D-2609435A4F71Q55512727-706BE287-CE40-4C28-B72E-A60D4CAEF56CQ58490673-893DDB74-60AE-491F-A96D-A4B1BF7F48FBQ58778034-B5A94B98-970B-4812-8EB1-B821A989D69F
P2860
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
@en
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
@nl
type
label
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
@en
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
@nl
prefLabel
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
@en
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
@nl
P2093
P2860
P50
P1476
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
@en
P2093
Alberto Martini
Ann M Reed
Clara Malattia
Clarissa Pilkington
Dragana Lazarevic
Elena Palmisani
Gerd Ganser
Inmaculada Calvo Penades
Jose Antonio Melo-Gomes
Malgorzata Wierzbowska
P2860
P304
P356
10.1136/ANNRHEUMDIS-2012-201483
P407
P577
2012-06-26T00:00:00Z